Literature DB >> 1315138

Hyperactivity, hyper-reactivity, and sensorimotor deficits induced by low doses of the N-methyl-D-aspartate non-competitive channel blocker MK801.

E L Hargreaves1, D P Cain.   

Abstract

Three doses of MK801 (0.05 mg/kg, 0.3 mg/kg and 1.0 mg/kg) were given systemically to adult male rats, which were then tested on a battery of previously learned, reactive and spontaneous behaviors. Hyperactivity, hyper-reactivity, reductions in rearing behavior and deficits in tongue extension were found at the 0.05 mg/kg dose. Similar, but more severe results were found at the 0.3 mg/kg dose, with the addition of difficulties in climbing, balancing on a beam, and abnormalities in orienting to tactile stimuli. A number of tasks could not be performed at the 1.0 mg/kg dose including tongue extension, orienting, balancing on a beam, and climbing. Additionally, abnormal postures, gaits, and swimming behaviors were observed at this dose. These results characterize the behavioral effects of MK801 as a syndrome of hyperactivity, hyper-reactivity, and sensorimotor deficits. Evidence of this syndrome was present at all three doses, including the 0.05 mg/kg dose, which previously has been claimed to induce deficits similar to hippocampal lesions. Learning literature employing MK801 is discussed in the context of the behavioral deficits found in this study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315138     DOI: 10.1016/s0166-4328(05)80249-9

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  A role for the beta isoform of protein kinase C in fear conditioning.

Authors:  E J Weeber; C M Atkins; J C Selcher; A W Varga; B Mirnikjoo; R Paylor; M Leitges; J D Sweatt
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.

Authors:  Li Guo; Thomas E Salt; Annelie Maass; Vy Luong; Stephen E Moss; Fred W Fitzke; M Francesca Cordeiro
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-02       Impact factor: 4.799

3.  Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.

Authors:  Andrea M Bradford; Kevin M Savage; Declan N C Jones; Mikhail Kalinichev
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

Review 4.  Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration.

Authors:  Brandon P Lucke-Wold; Ryan C Turner; Aric F Logsdon; James W Simpkins; Daniel L Alkon; Kelly E Smith; Yi-Wen Chen; Zhenjun Tan; Jason D Huber; Charles L Rosen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.

Authors:  Guy A Higgins; Theresa M Ballard; Michel Enderlin; Marie Haman; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

6.  Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.

Authors:  Kei Watase; Jennifer R Gatchel; Yaling Sun; Effat Emamian; Richard Atkinson; Ronald Richman; Hidehiro Mizusawa; Harry T Orr; Chad Shaw; Huda Y Zoghbi
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

Review 7.  Preclinical animal anxiety research - flaws and prejudices.

Authors:  Abdelkader Ennaceur; Paul L Chazot
Journal:  Pharmacol Res Perspect       Date:  2016-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.